In the BioHarmony Drug Report Database

"Preview" Icon

Pimecrolimus

Elidel (pimecrolimus) is a small molecule pharmaceutical. Pimecrolimus was first approved as Elidel on 2001-12-13. It is used to treat atopic dermatitis in the USA. The pharmaceutical is active against peptidyl-prolyl cis-trans isomerase FKBP1A.

 

Trade Name

 

Elidel
 

Common Name

 

pimecrolimus
 

ChEMBL ID

 

CHEMBL1200686
 

Indication

 

atopic dermatitis
 

Drug Class

 

Immunosuppressives: immunosuppressant, rapamycin derivatives

Image (chem structure or protein)

Pimecrolimus structure rendering